Why does a patient with a history of tuberculosis and peritoneal fluid showing signet‑ring cells and lymphocytic infiltrate present only with abdominal distension and constipation, without pain, nausea, vomiting, or weight loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Why Only Abdominal Distension and Constipation Without Other Symptoms?

The absence of pain, nausea, vomiting, or weight loss in a patient with peritoneal disease (particularly peritoneal tuberculosis or carcinomatosis) reflects the insidious, indolent nature of these conditions—they often present with minimal symptoms until advanced stages, and mechanical effects (ascites causing distension, bowel compression causing constipation) may dominate the clinical picture before systemic or inflammatory symptoms emerge.

Understanding the Paucisymptomatic Presentation

Peritoneal Tuberculosis: The "Great Mimicker"

Peritoneal tuberculosis is historically known as "the great mimicker" because it can present with highly variable and nonspecific symptoms 1. The classic triad of fever, weight loss, and abdominal pain is not always present—in fact, many patients present with atypical or minimal symptoms 1, 2.

  • Insidious onset: PTB develops slowly over weeks to months, allowing the body to adapt without triggering acute inflammatory responses that would cause pain or systemic symptoms 3, 2
  • Low-grade inflammation: Unlike acute peritonitis, tuberculous peritonitis causes chronic granulomatous inflammation that may not produce severe peritoneal irritation or pain 4, 5
  • Mechanical rather than inflammatory symptoms: The primary manifestations are often related to fluid accumulation (ascites causing distension) and mass effect (bowel compression causing constipation) rather than inflammatory mediators 2

Why Specifically No Pain?

The absence of abdominal pain is particularly notable but not uncommon:

  • Chronic adaptation: Slow accumulation of ascites allows peritoneal stretching to occur gradually without acute nociceptive stimulation 6
  • Non-irritative fluid: Tuberculous ascites is typically lymphocyte-predominant with low mesothelial cell counts, suggesting less acute peritoneal irritation compared to bacterial peritonitis 3
  • Lack of acute inflammation: Unlike spontaneous bacterial peritonitis (which presents with pain, fever, and peritoneal signs 7), tuberculous peritonitis causes granulomatous rather than acute suppurative inflammation

Why No Nausea, Vomiting, or Weight Loss?

Early or localized disease: If the disease is still relatively contained, systemic symptoms like anorexia and weight loss may not yet be prominent 6, 8. The guidelines note that in advanced ovarian cancer (which can mimic PTB), ascites and masses lead to bloating, nausea, anorexia, and early satiety 9, 6—but these are features of advanced disease with significant tumor burden.

Individual variation: Not all patients follow the textbook presentation. Recent case reports emphasize that PTB can present without the classic triad 1, 2. One case specifically noted a patient who "did not have any of these symptoms" (fever, weight loss, abdominal pain) and was only diagnosed incidentally during surgery 1.

Clinical Context: Signet-Ring Cells and Lymphocytic Infiltrate

The peritoneal fluid findings you describe (signet-ring cells with lymphocytic infiltrate) create diagnostic complexity:

Differential Diagnosis Considerations

  1. Peritoneal carcinomatosis: Signet-ring cells typically suggest adenocarcinoma (gastric, appendiceal, or ovarian mucinous origin). However, peritoneal carcinomatosis usually presents with more systemic symptoms as disease advances 9, 10

  2. Peritoneal tuberculosis: The lymphocytic infiltrate (particularly if lymphocyte-predominant with >75% lymphocytes and <1% mesothelial cells) strongly suggests PTB 3, 11. The combination of signet-ring cells with lymphocytic ascites is unusual but has been reported in cases where PTB mimics carcinomatosis 11, 4

  3. Mixed pathology: Given the TB history, consider concurrent PTB with another process, or misinterpretation of histiocytes/giant cells as signet-ring cells 4, 5

Diagnostic Algorithm for This Presentation

Immediate Next Steps

  1. Ascitic fluid analysis (if not already complete):

    • Cell count with differential (look for lymphocyte predominance >70% and mesothelial cells <1%) 3
    • Adenosine deaminase (ADA) level (>36-40 U/L suggests PTB with 100% sensitivity and 97% specificity) 12, 11
    • AFB staining and mycobacterial culture (though sensitivity is only ~50% for culture and near 0% for smear) 10, 12
    • M. tuberculosis PCR/NAAT 3, 11
    • Cytology (already done—signet-ring cells noted)

  2. Serum markers:

    • CA-125 (will be elevated in both PTB and peritoneal carcinomatosis—not specific) 10, 4
    • CEA and CA 19-9 if mucinous carcinoma suspected 9, 6

  3. Imaging:

    • CT abdomen/pelvis already done (look for smooth peritoneal thickening, omental infiltration, mesenteric lymphadenopathy—features of both PTB and carcinomatosis) 11, 4

  4. Definitive diagnosis:

    • Diagnostic laparoscopy with biopsy is the gold standard when initial tests are inconclusive 12, 3, 4, 5
    • Look for miliary nodules (PTB) vs. tumor implants (carcinomatosis)
    • Histopathology showing granulomas with Langhans giant cells confirms PTB 4, 5

Critical Pitfall to Avoid

Do not rely on CA-125 alone—it is elevated in both malignancy and PTB and can lead to misdiagnosis 10, 4. Multiple recent cases describe patients with markedly elevated CA-125 (>750 U/mL) who were initially suspected to have peritoneal carcinomatosis but ultimately had PTB 4, 5.

Why This Matters for Morbidity and Mortality

Delayed diagnosis of PTB significantly increases morbidity and mortality 13, 14. If this is tuberculous peritonitis:

  • Early anti-tuberculous therapy leads to rapid symptomatic improvement and near-complete radiological resolution within 4 months 5
  • Delayed treatment allows progression to bowel obstruction, malnutrition, and disseminated disease
  • Empiric anti-TB therapy should be strongly considered if ADA is elevated and clinical suspicion is high, even before culture confirmation 3, 5

Conversely, if this is peritoneal carcinomatosis, the prognosis and treatment are entirely different, making definitive tissue diagnosis essential 9, 6.

Bottom line: The paucisymptomatic presentation (only distension and constipation) is consistent with early or indolent peritoneal disease, most likely PTB given the TB history and lymphocytic ascites. Proceed urgently to ADA testing and consider diagnostic laparoscopy if initial microbiologic tests are negative 12, 3.

References

1
Research

Peritoneal tuberculosis with an atypical presentation. Surgical case report.

International journal of surgery case reports, 2024

Related Questions

In a patient with a history of tuberculosis whose peritoneal fluid shows only isolated signet‑ring‑type cells and a prominent lymphocytic infiltrate, should the fluid also be tested for tuberculosis (e.g., adenosine deaminase, TB PCR, and culture) in addition to the planned immunohistochemistry and cell‑block work‑up for ovarian carcinoma?
In a patient with new‑onset ascites suspected of tuberculous peritonitis, what ascitic fluid analyses are recommended?
What is the recommended work‑up and management for ascites when cytology shows numerous lymphocytes and a few atypical signet‑ring cells?
How should atrial tachycardia be evaluated and managed in a 72-year-old male?
Can clarithromycin and levofloxacin be used together safely, and what dosing, monitoring, and alternative therapy recommendations should be considered?
In a patient with fever, dry cough progressing to mildly productive cough, throat irritation, and night chills after three days of azithromycin without clinical improvement, which of the following antibiotics—doxycycline, azithromycin, amoxicillin, or cefuroxime—is appropriate?
Does artesunate cause clinically significant QT‑interval prolongation?
What is the appropriate management for constipation in a female patient after confirming no mechanical bowel obstruction?
In a 22-year-old female, what does minimal chronic inflammation of the gastric mucosa with small reactive lymphoid aggregates indicate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.